Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
1(10%)
Results Posted
25%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
4
40%
Ph phase_1
2
20%
Ph phase_2
3
30%

Phase Distribution

2

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
3(33.3%)
N/ANon-phased studies
4(44.4%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(4)
Terminated(2)
Other(3)

Detailed Status

Completed4
unknown3
Withdrawn1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
80.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (22.2%)
Phase 23 (33.3%)
N/A4 (44.4%)

Trials by Status

withdrawn110%
terminated110%
completed440%
recruiting110%
unknown330%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
PROCEDURE
Total Trials
10